These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2196630)

  • 21. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine.
    Strober M; Freeman R; Rigali J; Schmidt S; Diamond R
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):16-20. PubMed ID: 1537769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of chronic depression treated with imipramine.
    Kocsis JH; Sutton BM; Frances AJ
    J Clin Psychiatry; 1991 Feb; 52(2):56-9. PubMed ID: 1993636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M; Nardi AE; Mundim FD; Alves AB
    J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J; Wasieczko A
    Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls.
    Strober M; DeAntonio M; Schmidt-Lackner S; Pataki C; Freeman R; Rigali J; Rao U
    J Clin Psychiatry; 1999 Mar; 60(3):164-9. PubMed ID: 10192591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipramine in adolescent major depression: plasma level and clinical response.
    Ryan ND; Puig-Antich J; Cooper T; Rabinovich H; Ambrosini P; Davies M; King J; Torres D; Fried J
    Acta Psychiatr Scand; 1986 Mar; 73(3):275-88. PubMed ID: 3716845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
    Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine.
    Rausch JL; Moeller FG
    Psychiatry Res; 1991 Mar; 36(3):299-305. PubMed ID: 2062971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluvoxamine alone in the treatment of delusional depression.
    Gatti F; Bellini L; Gasperini M; Perez J; Zanardi R; Smeraldi E
    Am J Psychiatry; 1996 Mar; 153(3):414-6. PubMed ID: 8610832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMPI prediction of imipramine response: a replication study.
    Ramsey TA; Strand S; Stern S; Mendels J
    Neuropsychobiology; 1981; 7(2):94-8. PubMed ID: 7453954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imipramine in prepubertal major depressive disorders.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Tabrizi MA; King J; Goetz R; Davies M; Stiller RL
    Arch Gen Psychiatry; 1987 Jan; 44(1):81-9. PubMed ID: 3541830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desipramine plasma concentration and antidepressant response.
    Nelson JC; Jatlow P; Quinlan DM; Bowers MB
    Arch Gen Psychiatry; 1982 Dec; 39(12):1419-22. PubMed ID: 7149903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine.
    Berlanga C; Ortega-Soto HA; Ontiveros M; Senties H
    Psychiatry Res; 1992 Dec; 44(3):257-62. PubMed ID: 1289923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipramine and sexual dysfunction during the long-term treatment of recurrent depression.
    Karp JF; Frank E; Ritenour A; McEachran A; Kupfer DJ
    Neuropsychopharmacology; 1994 Aug; 11(1):21-7. PubMed ID: 7945740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of imipramine on depression and immune status in a sample of men with HIV infection.
    Rabkin JG; Harrison WM
    Am J Psychiatry; 1990 Apr; 147(4):495-7. PubMed ID: 1969246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.